CLINICAL ROLE -
Opinion
Video
Author(s):
Experts explore strategies for motivating treatment adherence and the importance of providers ensuring patients thoroughly understand their condition.
Ustekinumab-stba Receives FDA Approval for Autoimmune Disorder and Inflammatory Bowel Disease
Are OTC Proton Pump Inhibitors a Boon Or a Curse?
RHB-104 Plus Standard of Care Offers Extended Treatment for Crohn Disease
Heterogeneity Observed in Reporting on Drug-Drug Interactions With Proton Pump Inhibitors
Exploring the Connection Between Orange Peels, Gut Metabolism, and Heart Health
FDA Approves Vedolizumab for Maintenance Therapy to Treat Crohn Disease